Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Gener...
Five studies to be presented, with key research examining AI-based biomarker assessment and tumor m...
AI-powered whole-slide analysis provides insights into treatment response beyond conventional HER2 ...
Collaboration expands access to Lunit's AI-powered pathology platform by combining it with Discover...
Following years of clinical validation and proven real-world performance at Saint Göran, Stockholm ...
Three studies explore the relationship between tumor microenvironment, genomic alterations, and tre...
At ASCO 2026, Lunit will present precision patient stratification and biomarker-driven oncology res...
Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clini...
Lunit highlights enterprise AI adoption and FDA-cleared advancements at SBI 2026 SEOUL, South Korea...
* 13 oral presentations included, reaffirming the clinical value of AI-based medical image analys...
Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology produc...
Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk ass...
Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and ...
DURHAM, N.C. and SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Lunit, a leading provider of AI ...
Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardize...
The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, ...
LYNNWOOD, Wash., Oct. 16, 2025 /PRNewswire/ -- Volpara Health has qualified for the American Colleg...
AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, ad...
SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading pr...
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize b...
